Skip to main content

Table 2 Clinical characteristics of PTC + HT patients in the qPCR cohort (n = 35)

From: IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis

Clinicopathologic parameters

IL-17A Low

IL-17A High

p-value

N

N

Gender

  

0.380

 Male

0

1

 

 Female

15

19

 

Age (years)

 Mean

43.2 ± 12.0

41.1 ± 13.9

0.642

  < 55

13

17

0.889

  ≥ 55

2

3

 

Tumor size (cm)

 Mean

1.1 ± 0.8

1.1 ± 0.4

0.761

 ≤ 1

5

9

0.486

 > 1

10

11

 

Multifocal lesions

  

0.278

 Positive

8

7

 

 Negative

7

13

 

Extrathyroidal invasion

  

0.195

 Positive

4

2

 

 Negative

11

18

 

Lymph node metastasis

 

0.025*

 Positive

11

7

 

 Negative

4

13

 

TNM stage 8th

  

0.093

 I, II

13

20

 

 III, IV

2

0

 
  1. *p < 0.05
  2. PTC papillary thyroid cancer, HT Hashimoto’s thyroiditis